SFX by Ex Libris Inc.

Title:	Invariant natural killer T cell–natural killer cell interactions dictate transplantation outcome after α-galactosylceramide administration
Source:	Blood [0006-4971] Kuns, Rachel yr:2009

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Chen, N. "The current state of pancreas-kidney transplantation in China: The indications, surgical techniques and outcome." Journal of Huazhong University of Science and Technology. Medical Sciences (2009): 269-72.
description	2.	Schleinitz, N. "Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells." Clinical immunology 135.1 (2010): 26-32.
description	3.	Hayley, M. "Self-association of an activating natural killer cell receptor, KIR2DS1." PLoS ONE 6.8 (2011).
description	4.	Meenagh, A. "Investigation of killer cell immunoglobulin-like receptor gene diversity, KIR2DL1 and KIR2DS1." Tissue antigens 72.4 (2008): 383-391.
description	5.	Colucci, F. "How does variability of immune system genes affect placentation?" Placenta 32.8 (2011): 539-545.
description	6.	Demanet, W. "A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation." Leukemia 19.8 (2005): 1446-1451.
description	7.	Suarez-Alvarez, B. "Potential Role of NKG2D and Its Ligands in Organ Transplantation : New Target for Immunointervention." American journal of transplantation 9.2 (2009): 251-257.
description	8.	Bandyk D.F., Michael S S. "Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery." Journal of vascular surgery 43.4 (2006): 742-751.
description	9.	Nausch, N. "NKG2D ligands in tumor immunity." Oncogene 27.45 (2008): 5944-5958.
description	10.	Carlsten, M. "Natural killer cell-mediated lysis of freshly isolated human tumor cells." International journal of cancer 124.4 (2008): 757-762.
description	11.	Retière, C. "Large Spectrum of HLA-C Recognition by Killer Ig-like Receptor (KIR)2DL2 and KIR2DL3 and Restricted C1 Specificity of KIR2DS2: Dominant Impact of KIR2DL2/KIR2DS2 on KIR2D NK Cell Repertoire Formation." The journal of immunology 191.9 (2013): 4778-4788.
description	12.	Bieberich, C. "Regulated expression of a murine class I gene in transgenic mice." Molecular and cellular biology 6.4 (1986): 1339-1342.
description	13.	Eriksson, Johan G. "Mother's body size and placental size predict coronary heart disease in men." European heart journal 32.18 (2011): 2297-2303.
description	14.	Dorner, M. "A genetically humanized mouse model for hepatitis C virus infection." Nature 474.7350 (2011): 208-211.
description	15.	Giebel, S. "Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation." European journal of haematology 83.4 (2009): 343-356.
description	16.	Weisdorf, Daniel S. "Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia." Blood 113.3 (2009): 726-732.
description	17.	Cox, T. "Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology." Molecular Systems Biology 5.1 (2009): 279-279.
description	18.	Cook, Mark A A. "The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia." Blood (2004): 1521-6.
description	19.	Rajalingam, R. "Distinctive KIR and HLA diversity in a panel of north Indian Hindus." Immunogenetics 53.12 (2002): 1009-19.
description	20.	Moretta, A. "Human NK cells : from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias." Immunological reviews iews0105-2896August.1 (2008): 58-69.